Friday, November 17, 2017
 
 
Company News: Page (1) of 1 - 03/16/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Shire Receives European Approval for Label Extension of CINRYZE®?(C1 inhibitor [human]) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
 
(March 16, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Sales,Distribution,Manufacturing/Production,Marketing,Finance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Business Issues,Administration,Legal,Law & Regulations,Management,Finance/Accounting,Sales,Finance/Accounting,Sales, Inc.,IT (Information Technology),Medicine,Diet,Disease,Sexual,
Related Sites: DMN Newswire ,   IBN - Business ,   IBN - Security ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines